Photodynamic Therapy for Choroidal Neovascular Membrane Secondary to Optic Nerve Drusen
- Resource Type
- Authors
- Alejandro J Lavaque; Anish Shah; Peter E. Liggett; Nauman A Chaudhry
- Source
- Ophthalmic Surgery, Lasers and Imaging Retina. 36:70-72
- Subject
- medicine.medical_specialty
Visual acuity
genetic structures
medicine.diagnostic_test
business.industry
medicine.medical_treatment
Photodynamic therapy
Fluorescein angiography
Verteporfin
eye diseases
Ophthalmology
Choroidal neovascular membrane
Medicine
Metamorphopsia
In patient
sense organs
medicine.symptom
business
Optic Nerve Drusen
medicine.drug
- Language
- ISSN
- 2325-8179
2325-8160
The authors describe the use of photodynamic therapy with verteporfin for subfoveal choroidal neovascular membrane secondary to optic nerve drusen. A 28-year-old woman had a peripapillary choroidal neovascular membrane secondary to optic nerve drusen with significant metamorphopsia. Photodynamic therapy using verteporfin was performed. Visual acuity improved to 20/20 with resolution of metamorphopsia and absence of leakage on fluorescein angiography a few weeks after verteporfin therapy. The patient's condition remained stable for 16 months with 20/20 vision. Photodynamic therapy with verteporfin may be a useful treatment option in patients with choroidal neovascular membranes secondary to optic nerve drusen. [Ophthalmic Surg Lasers Imaging 2005;36:70–72.]